Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

VIKOR SCIENTIFIC, LLC

NPI: 1174009245 · CHARLESTON, SC 29403 · Clinical Medical Laboratory · NPI assigned 07/12/2018

$27.03M
Total Medicaid Paid
1,283,289
Total Claims
872,341
Beneficiaries
70
Codes Billed
2018-10
First Month
2024-12
Last Month

Provider Details

Authorized OfficialHARRELSON, SHEA (CO-FOUNDER)
NPI Enumeration Date07/12/2018

Related Entities

Other providers sharing the same authorized official: HARRELSON, SHEA

ProviderCityStateTotal Paid
SILVERPATH, INC. BLUE BELL PA $1.03M

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 7,367 $131K
2019 46,316 $1.08M
2020 217,629 $4.40M
2021 327,829 $4.92M
2022 386,604 $6.32M
2023 188,264 $5.82M
2024 109,280 $4.38M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism 124,124 81,624 $9.09M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 153,549 68,465 $5.69M
87481 61,606 48,496 $1.88M
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets 11,962 7,943 $930K
87653 87,962 65,806 $796K
87529 40,105 32,176 $760K
87641 76,905 59,706 $732K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 88,239 39,520 $725K
87500 79,008 61,464 $715K
87631 30,284 20,626 $630K
81514 6,723 6,131 $593K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe 42,508 34,567 $505K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe 37,683 29,991 $419K
87640 77,097 52,181 $398K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 37,737 27,230 $310K
87486 42,851 28,222 $300K
87541 41,591 27,341 $279K
87581 41,588 27,339 $276K
87625 28,587 22,128 $261K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe 29,260 22,493 $258K
87563 29,519 23,284 $253K
87511 34,436 25,917 $242K
87493 9,852 8,329 $133K
87556 10,522 8,764 $130K
87561 21,704 13,615 $120K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types 7,211 6,318 $98K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 4,140 3,744 $92K
87506 2,006 1,506 $75K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms 5,674 4,014 $64K
87505 895 798 $31K
87496 2,102 1,611 $26K
87498 2,046 1,554 $26K
87532 2,096 1,558 $25K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 2,875 1,658 $24K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,909 1,241 $19K
87471 2,666 1,875 $15K
81201 16 16 $14K
81317 17 17 $14K
81292 16 16 $12K
81298 16 16 $12K
81321 16 16 $11K
87507 118 95 $10K
81404 26 17 $8K
81295 16 16 $7K
81405 18 17 $6K
87634 1,163 837 $4K
87503 1,189 837 $4K
86769 155 110 $4K
87799 257 191 $2K
81226 138 93 $962.70
87551 37 31 $926.36
87533 39 28 $699.79
81328 114 78 $628.05
81225 154 106 $622.06
81231 117 80 $608.06
81230 117 80 $409.53
81241 49 37 $335.97
87512 14 13 $323.92
81291 117 80 $246.98
81240 49 37 $222.90
81319 17 17 $172.41
81227 119 80 $139.85
81401 19 13 $109.60
81203 16 16 $0.00
81162 16 16 $0.00
81323 16 16 $0.00
81300 16 16 $0.00
81355 48 36 $0.00
81297 16 16 $0.00
81294 16 16 $0.00